Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Author Title [ Type] Year Filters: Author is Polyzos, Stergios A [Clear All Filters]
Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease..
Aliment Pharmacol Ther. 51(2), 313-314.
(2020). Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals..
Endocr Rev. 34(3), 377-412.
(2013). Leptin in nonalcoholic fatty liver disease: a narrative review..
Metabolism. 64(1), 60-78.
(2015). Leptin in health and disease: facts and expectations at its twentieth anniversary..
Metabolism. 64(1), 5-12.
(2015). Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives..
Cell Metab. 18(1), 29-42.
(2013). Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma..
Surg Endosc. 26(1), 283-4.
(2012). Juvenile Paget disease..
Metabolism. 80, 15-26.
(2018). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2014). Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis..
Metabolism. 121, 154818.
(2021). Irisin in metabolic diseases..
Endocrine. 59(2), 260-274.
(2018). Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?.
Metabolism. 93, 100-102.
(2019). Irisin: A true, circulating hormone..
Metabolism. 64(12), 1611-8.
(2015). Irisin: a renaissance in metabolism?.
Metabolism. 62(8), 1037-44.
(2013). Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis..
Expert Opin Investig Drugs. 24(2), 145-57.
(2015). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Intracellular leptin signaling following effective weight loss..
Metabolism. 64(8), 888-95.
(2015). Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways..
Med Hypotheses. 72(5), 610.
(2009). Innate immunity and nonalcoholic fatty liver disease..
Ann Gastroenterol. 36(3), 244-256.
(2023).
(2019). Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021). Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review..
Expert Rev Endocrinol Metab. 5(5), 673-679.
(2010). infection and esophageal adenocarcinoma: a review and a personal view..
Ann Gastroenterol. 31(1), 8-13.
(2018). Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders..
J Neurogastroenterol Motil. 27(4), 653-654.
(2021). Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension..
Microorganisms. 9(11),
(2021). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017).